Robeco Institutional Asset Management B.V.
Position in LLY — ELI LILLY & Co
CIK 1418773
ROTTERDAM, P7
Position in LLY
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$600,744,096
-$179,973,382 QoQ
Shares Held
653,146
-10.1% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 67.59729065170728.ToString("F0")%
Shared 0.ToString("F0")%
None 32.402709348292724.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Robeco Institutional Asset Management B.V. holds $3,535,801,813 across 9 Drug Manufacturers - General names. LLY ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
3,250,326 | $706,913,401 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
653,146 | $600,744,096 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,354,394 | $467,501,891 | |
| 4 | JNJ |
Johnson & Johnson
|
1,721,249 | $420,742,105 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
6,733,740 | $408,401,331 | |
| 6 | PFE |
Pfizer Inc
|
11,138,434 | $312,767,226 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,322,293 | $279,348,624 | |
| 8 | AMGN |
Amgen Inc
|
566,919 | $199,470,450 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $600,744,096 | 653,146 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $780,717,478 | 726,465 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $622,460,741 | 815,807 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $526,997,358 | 676,045 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $579,951,524 | 702,197 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $598,827,276 | 775,683 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $732,622,767 | 826,944 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $653,813,829 | 722,143 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $606,571,522 | 779,695 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $389,926,846 | 668,920 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $444,245,183 | 827,072 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $474,458,155 | 1,011,681 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $308,372,615 | 897,946 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $403,539,080 | 1,103,048 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $462,238,202 | 1,429,529 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $448,628,296 | 1,383,673 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $424,194,153 | 1,481,280 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $427,528,344 | 1,547,782 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $439,847,805 | 1,903,691 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $464,105,506 | 2,022,070 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $396,050,553 | 2,119,958 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $447,469,898 | 2,650,260 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $393,707,888 | 2,659,829 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $424,759,764 | 2,587,159 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $223,324,773 | 1,609,896 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||